Utah Medical Products (NASDAQ:UTMD) Issues Quarterly Earnings Results

Utah Medical Products (NASDAQ:UTMD) announced its quarterly earnings results on Thursday. The medical instruments supplier reported $0.84 earnings per share for the quarter, Zacks reports. Utah Medical Products had a net margin of 28.90% and a return on equity of 9.13%.

Utah Medical Products Trading Down 4.7%

Shares of NASDAQ:UTMD traded down $3.23 during mid-day trading on Thursday, reaching $65.95. The stock had a trading volume of 4,274 shares, compared to its average volume of 14,471. The business’s 50 day moving average price is $67.79 and its 200 day moving average price is $65.30. Utah Medical Products has a 1 year low of $53.66 and a 1 year high of $75.75. The company has a market cap of $209.74 million, a P/E ratio of 19.51 and a beta of 0.36.

Utah Medical Products Announces Dividend

The company also recently disclosed a quarterly dividend, which was paid on Friday, July 3rd. Stockholders of record on Wednesday, June 17th were given a dividend of $0.31 per share. The ex-dividend date was Wednesday, June 17th. This represents a $1.24 dividend on an annualized basis and a dividend yield of 1.9%. Utah Medical Products’s dividend payout ratio (DPR) is presently 36.69%.

Wall Street Analyst Weigh In

Separately, Weiss Ratings reaffirmed a “hold (c-)” rating on shares of Utah Medical Products in a research report on Friday, May 22nd. One analyst has rated the stock with a Hold rating, Based on data from MarketBeat.com, Utah Medical Products presently has an average rating of “Hold”.

Institutional Investors Weigh In On Utah Medical Products

Several institutional investors have recently modified their holdings of the stock. Invesco Ltd. grew its position in shares of Utah Medical Products by 4.2% in the 4th quarter. Invesco Ltd. now owns 6,020 shares of the medical instruments supplier’s stock worth $337,000 after buying an additional 243 shares during the last quarter. O Shaughnessy Asset Management LLC lifted its holdings in shares of Utah Medical Products by 2.3% during the fourth quarter. O Shaughnessy Asset Management LLC now owns 14,903 shares of the medical instruments supplier’s stock worth $834,000 after purchasing an additional 337 shares during the period. &PARTNERS lifted its stake in Utah Medical Products by 11.6% during the 4th quarter. &PARTNERS now owns 3,796 shares of the medical instruments supplier’s stock valued at $212,000 after acquiring an additional 396 shares during the period. Comerica Bank boosted its holdings in Utah Medical Products by 435.6% in the third quarter. Comerica Bank now owns 541 shares of the medical instruments supplier’s stock valued at $34,000 after purchasing an additional 440 shares during the last quarter. Finally, State of Wyoming boosted its stake in shares of Utah Medical Products by 20.4% in the fourth quarter. State of Wyoming now owns 2,810 shares of the medical instruments supplier’s stock worth $157,000 after buying an additional 476 shares during the last quarter. 69.60% of the stock is owned by institutional investors.

Utah Medical Products Company Profile

Utah Medical Products, Inc (NASDAQ: UTMD), headquartered in Midvale, Utah, is a designer, manufacturer and marketer of single‐use medical devices focusing principally on respiratory therapy and patient monitoring applications. Since its founding in the late 1970s, the company has built a reputation for innovation in airway management and non‐invasive monitoring products used in acute and long‐term care settings.

The company’s core product portfolio includes tracheostomy tubes and related accessories, endotracheal tube holders, disposable catheters and sensors for measuring end‐tidal carbon dioxide (CO₂).